ADHS und hochfunktionale Autismus-Spektrum-Störungen

ZUSAMMENFASSUNG

ADHS und ASS sind früh beginnenden neuronale Entwicklungsstörungen, die häufig gemeinsam vorkommen. Sie haben anteilig eine gemeinsame genetische Grundlage, die sich sowohl in der Auftretenswahrscheinlichkeit beim selben Individuum als auch in den Familien der Betroffenen zeigt. Die Unterscheidung, um welche Störung es sich handelt oder ob diese als Komorbidität vorliegt, erfordert eine genaue diagnostische Längsschnittuntersuchung unter Einbeziehung von möglichst viel Fremdinformation. Die psychopharmakologische Behandlung der ADHS ist ähnlich wie beim alleinigen Vorliegen einer ADHS, allerdings sollten die eingesetzten Substanzen zunächst in deutlich niedrigerer Dosierung begonnen und nach Klinik gesteigert werden.

Abstract

ADHD and ASD are neurodevelopmental disorders beginning early in life and frequently occurring together. Both disorders share part of a common genetic basis, which can be seen in the higher probability that they co-occur in the same individual or in their families. To differentiate the two disorders and to assess if these are single disorders or comorbidities, a detailed diagnostic assessment including a third-party anamnesis about the long-term development has to be conducted. The psychopharmacological treatment of ADHD is similiar to the one without a comorbid ASD, but the medication should be started in a lower dosage than usual and be changed slowly according to the clinical symptoms.

Schlüsselwörter

Autismus - ADHS - Asperger-Syndrom - Komorbidität

Keywords

Autism - ADHD - Aspergers - Syndrom - comorbidity

• Literatur

• 1 Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet 2016; 387 10024 1240-50
• 2 Faraone SV, Asherson P, Banaschewski T. et al Attention-deficit/hyperactivity disorder. Nature reviews Disease primers 2015; 1: 15020
• 3 Banaschewski T, Becker K, Dopfner M. et al Attention-Deficit/Hyperactivity Disorder. Deutsches Arzteblatt international 2017; 114 (09) 149-59
• 4 Bachmann CJ, Philipsen A, Hoffmann F. ADHD in Germany: Trends in Diagnosis and Pharmacotherapy. Deutsches Arzteblatt international 2017; 114 (09) 141-8
• 5 Simon V, Czobor P, Balint S. et al Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. The British journal of psychiatry 2009; 194 (03) 204-11
• 6 Sibley MH, Mitchell JT, Becker SP. Method of adult diagnosis influences estimated persistence of childhood ADHD: a systematic review of longitudinal studies. The lancet Psychiatry 2016; 3 (012) 1157-65
• 7 Faraone SV, Biederman J, Monuteaux MC. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genetic epidemiology 2000; 18 (01) 1-16
• 8 Thapar A, Cooper M, Eyre O. et al What have we learnt about the causes of ADHD?. Journal of child psychology and psychiatry, and allied disciplines 2013; 54 (01) 3-16
• 9 Weintraub K. The prevalence puzzle: Autism counts. Nature 2011; 479 7371 22-4
• 10 Wing L, Potter D. The epidemiology of autistic spectrum disorders: is the prevalence rising?. Mental retardation and developmental disabilities research reviews 2002; 8 (03) 151-61
• 11 Tebartz van Elst L, Pick M. et al High-functioning autism spectrum disorder as a basic disorder in adult psychiatry and psychotherapy: psychopathological presentation, clinical relevance and therapeutic concepts. European archives of psychiatry and clinical neuroscience 2013; 263 (Suppl. 02) S189-96
• 12 Loomes R, Hull L, Mandy WPL. What Is the Male-to-Female Ratio in Autism Spectrum Disorder? A Systematic Review and Meta-Analysis. Journal of the American Academy of Child and Adolescent Psychiatry 2017; 56 (06) 466-74
• 13 Brugha TS, McManus S, Bankart J. et al Epidemiology of autism spectrum disorders in adults in the community in England. Archives of general psychiatry 2011; 68 (05) 459-65
• 14 Pilling S, Baron-Cohen S, Megnin-Viggars O. et al Recognition, referral, diagnosis, and management of adults with autism: summary of NICE guidance. BMJ 2012; 344: e4082
• 15 Tick B, Bolton P, Happe F. et al Heritability of autism spectrum disorders: a meta-analysis of twin studies. Journal of child psychology and psychiatry, and allied disciplines 2016; 57 (05) 585-95
• 16 Lord C, Elsabbagh M, Baird G. et al Autism spectrum disorder. Lancet 2018; 392 10146 508-20
• 17 Tebartz van Elst L. Autismus und ADHS. Zwischen Normvariante, Persönlichkeitsstörung und neuropsychiatrischer Krankheit. Stuttgart: Kohlhammer Verlag; 2018
• 18 Grobe TG. [Regional differences of ADHD diagnosis rates in health insurance data from 2005 to 2015 : Methodological considerations and results]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2017; 60 (012) 1336-45
• 19 Leitlinien. AdWMFASK. Autismus-Spektrum-Störungen im Kindes-, Jugend- und Erwachsenenalter, Teil 1: Diagnostik – Interdisziplinäre S3-Leitlinie der DGKJP und der DGPPN sowie der beteiligten Fachgesellschaften, Berufsverbände und Patientenorganisationen. Konsensuskonferenz am 24/25042015
• 20 Association AP. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: 2013
• 21 Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychological medicine 2006; 36 (02) 159-65
• 22 Sibley MH. et al When diagnosing ADHD in young adults emphasize informant reports, DSM items, and impairment. Journal of consulting and clinical psychology 2012; 80 (06) 1052-61
• 23 Manor I, Vurembrandt N, Rozen S. et al Low self-awareness of ADHD in adults using a self-report screening questionnaire. European psychiatry 2012; 27 (05) 314-20
• 24 Morstedt B, Corbisiero S, Bitto H. et al Attention-Deficit/Hyperactivity Disorder (ADHD) in Adulthood: Concordance and Differences between Self- and Informant Perspectives on Symptoms and Functional Impairment. PloS one 2015; 10 (011) e0141342
• 25 Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. The Psychiatric clinics of North America 2004; 27 (02) 187-201
• 26 Culpepper L, Mattingly G. A practical guide to recognition and diagnosis of ADHD in adults in the primary care setting. Postgraduate medicine 2008; 120 (03) 16-26
• 27 Kalbag AS, Levin FR. Adult ADHD and substance abuse: diagnostic and treatment issues. Substance use & misuse 2005; 40 13–14 1955-89
• 28 Adler LA. Clinical presentations of adult patients with ADHD. The Journal of clinical psychiatry 2004; 65 (Suppl. 03) 8-11
• 29 Jensen CM, Steinhausen HC. Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. Attention deficit and hyperactivity disorders 2015; 7 (01) 27-38
• 30 Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. The Journal of clinical psychiatry 1998; 59 (Suppl. 07) 50-8
• 31 Milberger S. et al ADHD is associated with early initiation of cigarette smoking in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 1997; 36 (01) 37-44
• 32 Biederman J, Wilens T, Mick E. et al Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry 1997; 36 (01) 21-9
• 33 Agnew-Blais JC, Polanczyk GV, Danese A. et al Young adult mental health and functional outcomes among individuals with remitted, persistent and late-onset ADHD. The British journal of psychiatry 2018; 213 (03) 526-34
• 34 Caye A, Swanson J, Thapar A. et al Life Span Studies of ADHD-Conceptual Challenges and Predictors of Persistence and Outcome. Current psychiatry reports 2016; 18 (012) 111
• 35 Luderer M, Kaplan-Wickel N, Richter A. et al Screening for adult attention-deficit/hyperactivity disorder in alcohol dependent patients: Underreporting of ADHD symptoms in self-report scales. Drug and alcohol dependence 2019; 195: 52-8
• 36 Ilbegi S, Groenman AP, Schellekens A. et al Substance use and nicotine dependence in persistent, remittent, and late-onset ADHD: a 10-year longitudinal study from childhood to young adulthood. Journal of neurodevelopmental disorders 2018; 10 (01) 42
• 37 Molina BSG, Howard AL, Swanson JM. et al Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study. Journal of child psychology and psychiatry, and allied disciplines 2018; 59 (06) 692-702
• 38 Erskine HE, Norman RE, Ferrari AJ. et al Long-Term Outcomes of Attention-Deficit/Hyperactivity Disorder and Conduct Disorder: A Systematic Review and Meta-Analysis. Journal of the American Academy of Child and Adolescent Psychiatry 2016; 55 (010) 841-50
• 39 Fayyad J. et al The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. Attention deficit and hyperactivity disorders 2017; 9 (01) 47-65
• 40 Tebartz van Elst L. Das Asperger-Syndrom im Erwachsenenalter und andere hochfunktionale Autismus-spektrum-Störungen. Elst LTv (Hrsg.) Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft; 2016
• 41 Dean M, Harwood R, Kasari C. The art of camouflage: Gender differences in the social behaviors of girls and boys with autism spectrum disorder. Autism 2017; 21 (06) 678-89
• 42 Cath DC, Ran N, Smit JH. et al Symptom overlap between autism spectrum disorder, generalized social anxiety disorder and obsessive-compulsive disorder in adults: a preliminary case-controlled study. Psychopathology 2008; 41 (02) 101-10
• 43 Barneveld PS, Pieterse J, de Sonneville L. et al Overlap of autistic and schizotypal traits in adolescents with Autism Spectrum Disorders. Schizophrenia research 2011; 126 1–3 231-6
• 44 Tyson KE, Cruess DG. Differentiating high-functioning autism and social phobia. Journal of autism and developmental disorders 2012; 42 (07) 1477-90
• 45 S3-Leitlinie. Autismus-Spektrum-Störungen im Kindes-, Jugend- und Erwachsenenalter Teil 1: Diagnostik [Internet]. 2016 https://www.awmf.org/leitlinien/detail/ll/028-018.html
• 46 Lesch KP, Selch S, Renner TJ. et al Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Molecular psychiatry 2011; 16 (05) 491-503
• 47 Williams NM, Zaharieva I, Martin A. et al Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010; 376 9750 1401-8
• 48 Stergiakouli E, Hamshere M, Holmans P. et al Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. The American journal of psychiatry 2012; 169 (02) 186-94
• 49 Williams NM, Franke B, Mick E. et al Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. The American journal of psychiatry 2012; 169 (02) 195-204
• 50 Castellanos FX, Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nature reviews Neuroscience 2002; 3 (08) 617-28
• 51 Lichtenstein P, Carlstrom E, Rastam M. et al The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. The American journal of psychiatry 2010; 167 (011) 1357-63
• 52 Panagiotidi M, Overton PG, Stafford T. Co-Occurrence of ASD and ADHD Traits in an Adult Population. Journal of attention disorders 2017; 1087054717720720
• 53 Leitner Y. The co-occurrence of autism and attention deficit hyperactivity disorder in children – what do we know?. Frontiers in human neuroscience 2014; 8: 268
• 54 Colombi C, Ghaziuddin M. Neuropsychological Characteristics of Children with Mixed Autism and ADHD. Autism research and treatment 2017; 2017: 5781781
• 55 Houghton R, Ong RC, Bolognani F. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States. Autism research : official journal of the International Society for Autism Research 2017; 10 (012) 2037-47
• 56 Visser JC, Rommelse NN, Greven CU. et al Autism spectrum disorder and attention-deficit/hyperactivity disorder in early childhood: A review of unique and shared characteristics and developmental antecedents. Neuroscience and biobehavioral reviews 2016; 65: 229-63
• 57 Musser ED. et al Shared familial transmission of autism spectrum and attention-deficit/hyperactivity disorders. Journal of child psychology and psychiatry, and allied disciplines 2014; 55 (07) 819-27
• 58 Bonatto SJ, Kerner M, Merelles S. et al The prevalence of symptoms of attention-deficit/hyperactivity disorder in parents of children with autism spectrum disorder. Psychiatry research 2016; 240: 1-3
• 59 Miller M, Musser ED, Young GS. et al Sibling Recurrence Risk and Cross-aggregation of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder. JAMA pediatrics 2019; 173 (02) 147-52
• 60 Tick B, Colvert E, McEwen F. et al Autism Spectrum Disorders and Other Mental Health Problems: Exploring Etiological Overlaps and Phenotypic Causal Associations. Journal of the American Academy of Child and Adolescent Psychiatry 2016; 55 (02) 106-13e4
• 61 Stergiakouli E, Davey Smith G, Martin J. et al Shared genetic influences between dimensional ASD and ADHD symptoms during child and adolescent development. Molecular autism 2017; 8: 18
• 62 Ghirardi L, Brikell I, Kuja-Halkola R. et al The familial co-aggregation of ASD and ADHD: a register-based cohort study. Molecular psychiatry 2018; 23 (02) 257-62
• 63 Jokiranta-Olkoniemi E. et al Attention-deficit/hyperactivity disorder and risk for psychiatric and neurodevelopmental disorders in siblings. Psychological medicine 2019; 49 (01) 84-91
• 64 Jokiranta-Olkoniemi E. et al Risk of Psychiatric and Neurodevelopmental Disorders Among Siblings of Probands With Autism Spectrum Disorders. JAMA psychiatry 2016; 73 (06) 622-9
• 65 Chien YL, Chou MC, Chiu YN. et al ADHD-related symptoms and attention profiles in the unaffected siblings of probands with autism spectrum disorder: focus on the subtypes of autism and Asperger’s disorder. Molecular autism 2017; 8: 37
• 66 Ozonoff S, Young GS, Carter A. et al Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics 2011; 128 (03) e488-95
• 67 Sandin S, Lichtenstein P, Kuja-Halkola R. et al The familial risk of autism. JAMA 2014; 311 (017) 1770-7
• 68 Anttila V, Bulik-Sullivan B, Finucane HK. et al Analysis of shared heritability in common disorders of the brain. Science 2018; 360: 6395
• 69 Lee SH, Ripke S, Neale BM. et al Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature genetics 2013; 45 (09) 984-94
• 70 Martin J, Cooper M, Hamshere ML. et al Biological overlap of attention-deficit/hyperactivity disorder and autism spectrum disorder: evidence from copy number variants. Journal of the American Academy of Child and Adolescent Psychiatry 2014; 53 (07) 761-70e26
• 71 Rao PA, Landa RJ. Association between severity of behavioral phenotype and comorbid attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders. Autism 2014; 18 (03) 272-80
• 72 Berenguer C, Rosello B, Colomer C. et al Children with autism and attention deficit hyperactivity disorder. Relationships between symptoms and executive function, theory of mind, and behavioral problems. Research in developmental disabilities 2018; 83: 260-9
• 73 Antshel KM, Zhang-James Y, Wagner KE. et al An update on the comorbidity of ADHD and ASD: a focus on clinical management. Expert review of neurotherapeutics 2016; 16 (03) 279-93
• 74 Doyle AE, Vuijk PJ, Doty ND. et al Cross-Disorder Cognitive Impairments in Youth Referred for Neuropsychiatric Evaluation. Journal of the International Neuropsychological Society 2018; 24 (01) 91-103
• 75 Andersen PN, Hovik KT, Skogli EW. et al Symptoms of ADHD in children with high-functioning autism are related to impaired verbal working memory and verbal delayed recall. PloS one 2013; 8 (05) e64842
• 76 Ashwood KL, Tye C, Azadi B. et al Brief Report: Adaptive Functioning in Children with ASD, ADHD and ASD + ADHD. Journal of autism and developmental disorders 2015; 45 (07) 2235-42
• 77 Lyall K, Schweitzer JB, Schmidt RJ. et al Inattention and hyperactivity in association with autism spectrum disorders in the CHARGE study. Research in autism spectrum disorders 2017; 35: 1-12
• 78 Sinzig J, Morsch D, Lehmkuhl G. Do hyperactivity, impulsivity and inattention have an impact on the ability of facial affect recognition in children with autism and ADHD?. European child & adolescent psychiatry 2008; 17 (02) 63-72
• 79 Downs A, Smith T. Emotional understanding, cooperation, and social behavior in high-functioning children with autism. Journal of autism and developmental disorders 2004; 34 (06) 625-35
• 80 Yuill N, Lyon J. Selective difficulty in recognising facial expressions of emotion in boys with ADHD. General performance impairments or specific problems in social cognition?. European child & adolescent psychiatry 2007; 16 (06) 398-404
• 81 van der Meer JM. et al Are autism spectrum disorder and attention-deficit/hyperactivity disorder different manifestations of one overarching disorder? Cognitive and symptom evidence from a clinical and population-based sample. Journal of the American Academy of Child and Adolescent Psychiatry 2012; 51 (011) 1160-72e3
• 82 Oerlemans AM, van der Meer JM, van Steijn DJ. et al Recognition of facial emotion and affective prosody in children with ASD (+ ADHD) and their unaffected siblings. European child & adolescent psychiatry 2014; 23 (05) 257-71
• 83 Flouri E, Midouhas E, Charman T. et al Poverty and the Growth of Emotional and Conduct Problems in Children with Autism With and Without Comorbid ADHD. Journal of autism and developmental disorders 2015; 45 (09) 2928-38
• 84 Langfassung der interdisziplinären evidenz- und konsensbasierten (S3) Leitlinie „Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Kindes-, Jugend- und Erwachsenenalter. 2018 https://www.awmf.org/leitlinien/detail/ll/028-045.html
• 85 Patra S. et al Atomoxetine for attention deficit hyperactivity disorder in children and adolescents with autism: A systematic review and meta-analysis. Autism research 2019; 12 (04) 542-52
• 86 Research Units on Pediatric Psychopharmacology Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Archives of general psychiatry 2005; 62 (011) 1266-74
• 87 Jahromi LB, Kasari CL, McCracken JT. et al Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. Journal of autism and developmental disorders 2009; 39 (03) 395-404
• 88 Harfterkamp M, van de Loo-Neus G, Minderaa RB. et al A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2012; 51 (07) 733-41
• 89 Harfterkamp M, Buitelaar JK, Minderaa RB. et al Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study. Journal of child and adolescent psychopharmacology 2013; 23 (03) 194-9
• 90 Scahill L, McCracken JT, King BH. et al Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder. The American journal of psychiatry 2015; 172 (012) 1197-206
• 91 Goel R, Hong JS, Findling RL. et al An update on pharmacotherapy of autism spectrum disorder in children and adolescents. International review of psychiatry 2018; 30 (01) 78-95
• 92 Sturman N, Deckx L, van Driel ML. Methylphenidate for children and adolescents with autism spectrum disorder. The Cochrane database of systematic reviews 2017; 11: Cd011144
• 93 Naguy A. Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD. The Journal of nervous and mental disease 2017; 205 (09) 738
• 94 Arnold LE, Aman MG, Cook AM. et al Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45 (010) 1196-205
• 95 Harfterkamp M. et al Atomoxetine in autism spectrum disorder: no effects on social functioning; some beneficial effects on stereotyped behaviors, inappropriate speech, and fear of change. Journal of child and adolescent psychopharmacology 2014; 24 (09) 481-5
• 96 Reichow B, Volkmar FR, Bloch MH. Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders. Journal of autism and developmental disorders 2013; 43 (010) 2435-41